Two Calif. hospitals hit by hackers

Two Southern California hospitals are the victims of hackers, according to a report from California Healthline.

Prime Healthcare Services, a fast-growing national hospital chain that operates 42 hospitals in 14 states, said a malware attack disrupted computer servers on Friday at two of its California hospitals, Chino Valley Medical Center in Chino and Desert Valley Hospital in Victorville.

The company said the cyberattack didn’t affect patient safety or compromise patient records.

“This is similar to challenges hospitals across the country are facing, and we have taken extraordinary steps to protect and expeditiously find a resolution to this disruption,” said Fred Ortega, a spokesman for Prime Healthcare.

The FBI is investigating the malware attack.

“We received a malware attack and we were able to identify the issue early on,” Ortega said. “The concern now is to let law enforcement do their thing and find the culprit.”

The two hospitals affected remain operational and steps are being taken to restore their computer systems to full functionality, according to the report. Ortega said some IT systems were shut down by hospital staff as a preventive measure to prevent the spread of malicious software.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.